Israel Innovation Authority R&D Fund
The Israel Innovation Authority R&D Fund supports Israeli corporations developing new products or upgrading existing technology, with financial support of 20%-50% of approved R&D expenditure and additional or preferential terms described by the Authority.
Israel Innovation Authority R&D Fund
At a glance
| Field | Current information |
|---|---|
| Program | Israel Innovation Authority R&D Fund |
| Status | Open yearlong according to the Authority’s current English program page |
| Funding type | Public R&D support, with repayment through royalties from sales if the supported project reaches commercialization |
| Funding level | 20%-50% of approved R&D expenditure |
| Additional terms | The Authority describes extra support for eligible Development Zones and areas around the Gaza Strip, plus preferential terms for certain startup corporations |
| Applicants | Israeli corporations at different stages and from all industrial sectors that are developing or upgrading technology |
| Official route | Israel Innovation Authority R&D Fund |
| Detailed requirements | The Authority directs Israeli companies to its Hebrew website for the requirements and application process |
Current program status
This page now describes the R&D Fund, which is the current official route for requests that were previously associated with the Early Stage Companies Incentive Program. The Israel Innovation Authority’s R&D Fund page says that the earlier program was merged into the R&D Fund and that those requests are submitted through the R&D Fund. The opportunity should therefore be evaluated under the R&D Fund’s current description, not under a separate early-stage program page.
The Authority’s current page labels the R&D Fund as open yearlong. That is why the metadata uses ongoing rather than a calendar deadline. Year-round availability does not remove the need to check the live Hebrew requirements, any submission instructions, or any project-specific conditions before preparing an application. It means that the page does not identify one annual closing date for the general R&D Fund route.
The Authority’s program directory also lists the R&D Fund as a current program. It separately lists the Startup Fund, which is a different route for early-stage companies. A young company should compare those two options rather than assume that every early-stage financing need belongs in the R&D Fund. This page is specifically about R&D Fund support for an Israeli corporation’s development or technology-upgrade project.
What the R&D Fund supports
The R&D Fund supports commercial companies that are developing new products or upgrading an existing technology. The Authority describes the program as applying to Israeli corporations’ R&D activity and says it is available across industrial sectors. The examples on the official page include hardware, software, communications, complex systems, life sciences, medical devices, cyber, Internet of Things, fintech, and cleantech.
That broad scope does not mean that every business expense qualifies. The useful test is whether the proposed work is a genuine technology development or technology-upgrade project that can be evaluated as R&D. A request should make the technical work visible: what is being developed, what existing capability is being upgraded, what uncertainty the work addresses, and what result the project is intended to produce.
The Fund is relevant to a company that has a commercial purpose but still faces development risk. A proposal may concern a new product, a substantial improvement to an existing product, or technology work needed to create a stronger product and market position. The description should connect the technical work to the company’s commercial purpose without turning the application into a general business-plan request.
Funding amount and repayment model
The Authority states that the R&D Fund provides financial support of between 20% and 50% of approved R&D expenditure. The percentage is applied to approved expenditure, not automatically to every cost in a company’s budget. The final approved amount therefore depends on the project scope, the expenditure that the Authority accepts, and the funding terms applicable to the company and project.
The official page also identifies two types of terms that can increase support for eligible applicants:
- Companies operating in Development Zones may be eligible for an additional 10% support.
- Companies operating in areas around the Gaza Strip may be eligible for an additional 25% support.
The same page describes preferential funding terms for a startup corporation owned by minority population, Ultra-Orthodox, and/or women entrepreneurs. It states that these terms can reach up to 75% funding in the first year and 70% in the second year. These are not automatic rates for every startup. They are conditions to investigate in the current requirements, and an applicant should not put a preferential percentage into its budget without confirming that the company satisfies the applicable definition.
The Authority says that companies receiving financing undertake to repay the support through royalty payments from sales, but only if the project successfully reaches commercialization. Founders should still read the current legal and financial terms carefully: a royalty obligation is not unrestricted cash, and the precise repayment conditions belong in the application review.
Who can apply
The Authority identifies Israeli corporations at different stages and from all industrial sectors as the audience for the R&D Fund. The company must be engaged in technological innovation and interested in developing or upgrading an existing product or technology. This is broader than a program limited to companies below a certain age, revenue level, or fundraising amount. Those old early-stage thresholds are not carried forward here because they are not part of the current English R&D Fund description.
A practical fit check should cover four questions:
- Is the applicant an Israeli corporation that can submit under the Authority’s current company requirements?
- Is there a defined product-development or technology-upgrade project rather than only a general need for operating cash?
- Can the company explain the technical uncertainty, development work, and expected result?
- Can the company present an expenditure plan that separates the proposed R&D work from unrelated commercial, administrative, or routine costs?
An affirmative answer is not a guarantee of eligibility. It is a way to decide whether it is worth reading the Hebrew requirements and preparing a submission. The Authority’s wording covers startups as well as investment-intensive corporations, so company maturity alone does not decide the outcome. The project’s technological purpose, the applicant’s status, and the applicable funding rules all matter.
How to prepare an application
The English page gives the program’s main terms and directs Israeli companies to the Authority’s Hebrew website for the detailed requirements and application process. Use that Hebrew route as the controlling source for forms, annexes, definitions, submission instructions, and any current procedural notices.
Before opening the detailed process, assemble a concise project record. It should answer the following questions in the same order that a reviewer would need to understand them:
1. Define the product or upgrade
Describe the product being developed or the existing technology being upgraded. Explain the user or customer problem, the current technical position, and what the proposed work will change. Avoid presenting a broad corporate vision as the project itself. The application should make it possible to identify the actual development effort that support would fund.
2. Explain the technical uncertainty
State what is not yet solved. This might be a performance target, an integration problem, a reliability issue, a manufacturing challenge, a data or systems constraint, or another technical barrier. Then describe the work planned to reduce that uncertainty. A credible project is specific about both the desired result and the possibility that a technical approach may need to change.
3. Set measurable work packages
Break the project into work packages with an owner, a technical output, and a way to assess completion. For example, a work package might produce a prototype revision, a test result, an integration demonstration, or a validated performance measurement. The work packages should be understandable without requiring the reviewer to infer how the budget relates to the development plan.
4. Build the R&D expenditure plan
Prepare the budget around the proposed R&D work. For every material line, record the work package it supports and the evidence behind the estimate. Keep routine sales, general administration, and unrelated company expenses separate from the project budget. The Authority’s percentage applies to approved R&D expenditure, so clarity about what is being requested is central to the funding calculation.
5. Check company and location conditions
Confirm the company’s Israeli corporate status and review the current Hebrew requirements for the applicant. If the company claims eligibility for Development Zone or Gaza-area additional support, document the relevant operating location and verify the definition used by the Authority. If the company seeks preferential startup terms, verify the ownership and entrepreneur conditions before relying on the higher rate.
6. Follow the live Hebrew process
Use the Hebrew requirements page linked or referenced by the Authority to identify the current submission route. Follow the current form structure and provide the annexes and declarations requested there. The English summary is useful for understanding the program, but it is not a substitute for the detailed Hebrew instructions.
7. Preserve a submission record
Keep the final narrative, budget, technical plan, supporting documents, and submission confirmation together. Record which version was submitted and which funding terms were used. This makes it easier to answer follow-up questions and to distinguish approved expenditure from later company spending.
What a strong project description should show
A useful R&D Fund application should connect five elements without gaps:
- Company: why this Israeli corporation is the applicant and what capability it already has.
- Problem: what customer, industrial, or technical need the product addresses.
- Technology: what is new or being substantially upgraded and why development work is required.
- Plan: what the team will do, when it will do it, and how it will measure progress.
- Commercial purpose: how a successful technical result can support a product or improved technology for the market.
The commercial explanation should not replace the technical case. The Authority describes the Fund as supporting innovative, high-risk R&D aimed at future products and technologies. A proposal should therefore show both the development risk and the reason the result matters commercially. A market claim without a technical plan is incomplete; a technical plan with no product purpose is also incomplete.
Questions to settle before submission
Use the current Hebrew instructions to answer these questions rather than relying on older Early Stage pages or third-party summaries:
- What legal entity is eligible to apply?
- Which project costs and personnel activities may be included as approved R&D expenditure?
- What evidence is required for the company, its ownership, its technology, and its location?
- Does the project qualify for the standard range or for an additional or preferential term?
- What reporting, approval, and royalty obligations apply if the project is funded?
- Which submission form and annexes are required for the current process?
These questions are intentionally operational. The current English page confirms the program’s purpose and headline terms, but it directs applicants to Hebrew materials for the detailed requirements. A careful applicant should treat those materials as the source for the final compliance checklist.
Common mistakes to avoid
Treating the old program name as the current route
The former Early Stage program is not the name to use for this opportunity. The Authority says those requests were merged into the R&D Fund. Use the R&D Fund page and current Hebrew process instead.
Treating the maximum range as an entitlement
The 20%-50% range describes the Authority’s stated financial support range. It does not mean that every applicant receives 50%, nor that every budget line is approved. Base the request on eligible project work and verify the applicable rate.
Copying preferential terms without checking the definition
The Authority describes additional regional support and preferential startup terms, but the company must confirm that it fits the current conditions. Keep the standard budget and the eligibility evidence clear before adding a preferential-rate scenario.
Mixing R&D and general runway
The Fund is for an R&D project. A request that reads like a request for unrestricted runway will be difficult to evaluate. Show the technical work, the expenditure, and the expected product or technology result.
Ignoring the Hebrew requirements page
The English page explicitly directs Israeli companies to the Hebrew site for requirements and application details. Do not rely on this summary for form fields, annexes, or legal wording that may be specific to the current process.
Bottom line
The Israel Innovation Authority R&D Fund is the current opportunity to assess for an Israeli corporation developing a new product or upgrading existing technology. The Authority says the program is open yearlong and offers support of 20%-50% of approved R&D expenditure, with extra or preferential terms in specified circumstances. The support is tied to an assessed R&D project, and repayment is through royalties from sales if the project reaches commercialization.
The sensible next step is to open the official R&D Fund page, follow its Hebrew requirements route, and test the company and project against the current definitions. Prepare the technical scope and expenditure plan first, confirm any location or ownership-based terms, and submit only through the current Authority process. The program name, eligibility framing, rates, and application instructions should all come from the current R&D Fund materials rather than from the discontinued standalone Early Stage description.